| 1 |
32219694 | In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions. | 2020 Jun |
2 |
| 2 |
32279279 | The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions. | 2020 Dec |
1 |
| 3 |
26481538 | Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study. | 2015 Dec |
1 |
| 4 |
11037108 | Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates. | 2000 Aug |
2 |
| 5 |
9820175 | Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent. | 1998 Nov |
1 |
| 6 |
7935340 | Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. | 1994 Sep |
1 |
| 7 |
2233418 | Parkinson's disease and cytochrome P450: a possible link? | 1990 Aug |
1 |
| 8 |
2910635 | In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone. | 1989 Jan |
1 |
| 9 |
3186722 | Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. | 1988 Nov |
1 |
| 10 |
3689440 | Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiency. | 1987 Dec 1 |
3 |
| 11 |
2874666 | The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. | 1986 May |
3 |
| 12 |
3745165 | Debrisoquine/sparteine-type polymorphism of drug oxidation. Purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol. | 1986 Sep 5 |
1 |
| 13 |
3966916 | Genetic polymorphism in drug oxidation: in vitro studies of human debrisoquine 4-hydroxylase and bufuralol 1'-hydroxylase activities. | 1985 Jan 1 |
1 |
| 14 |
6508804 | Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism)--increased Michaelis is Constant (Km) and loss of stereoselectivity of bufuralol 1'-hydroxylation in poor metabolizers. | 1984 Nov 30 |
1 |